PortfoliosLab logoPortfoliosLab logo
ICLR vs. CI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ICLR vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ICON Public Limited Company (ICLR) and Cigna Corporation (CI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ICLR achieves a -17.98% return, which is significantly lower than CI's 6.37% return. Over the past 10 years, ICLR has underperformed CI with an annualized return of 8.12%, while CI has yielded a comparatively higher 9.53% annualized return.


ICLR

1D
-2.19%
1M
20.40%
YTD
-17.98%
6M
-19.59%
1Y
10.85%
3Y*
-12.60%
5Y*
-7.48%
10Y*
8.12%

CI

1D
3.14%
1M
3.25%
YTD
6.37%
6M
10.29%
1Y
-4.86%
3Y*
5.21%
5Y*
4.73%
10Y*
9.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ICLR vs. CI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ICLR
ICON Public Limited Company
-17.98%-13.11%-25.92%45.72%-37.28%58.84%13.21%33.29%15.21%49.14%
CI
Cigna Corporation
6.37%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%

Correlation

The correlation between ICLR and CI is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since May 18, 1998

0.18

Fundamentals

EPS

ICLR:

$4.36

CI:

$23.59

PE Ratio

ICLR:

34.24

CI:

12.27

PEG Ratio

ICLR:

0.90

CI:

0.71

PS Ratio

ICLR:

0.95

CI:

0.28

Total Revenue (TTM)

ICLR:

$8.25B

CI:

$277.94B

Gross Profit (TTM)

ICLR:

$2.18B

CI:

$19.38B

EBITDA (TTM)

ICLR:

$823.57M

CI:

$10.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ICLR vs. CI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ICLR
ICLR Risk / Return Rank: 4848
Overall Rank
ICLR Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
ICLR Sortino Ratio Rank: 4848
Sortino Ratio Rank
ICLR Omega Ratio Rank: 5353
Omega Ratio Rank
ICLR Calmar Ratio Rank: 4646
Calmar Ratio Rank
ICLR Martin Ratio Rank: 4646
Martin Ratio Rank

CI
CI Risk / Return Rank: 3434
Overall Rank
CI Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
CI Sortino Ratio Rank: 3131
Sortino Ratio Rank
CI Omega Ratio Rank: 3131
Omega Ratio Rank
CI Calmar Ratio Rank: 3535
Calmar Ratio Rank
CI Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ICLR vs. CI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ICON Public Limited Company (ICLR) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ICLRCIDifference
Sharpe ratioReturn per unit of total volatility

+0.30

Sortino ratioReturn per unit of downside risk

+0.69

Omega ratioGain probability vs. loss probability

1.12

1.00

+0.12

Calmar ratioReturn relative to maximum drawdown

0.18

-0.18

+0.36

Martin ratioReturn relative to average drawdown

0.40

-0.34

+0.74

ICLR vs. CI - Sharpe Ratio Comparison

The current ICLR Sharpe Ratio is 0.16, which is higher than the CI Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of ICLR and CI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ICLRCIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.16

-0.15

+0.30

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

0.17

-0.33

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.31

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.28

0.34

-0.07

Drawdowns

ICLR vs. CI - Drawdown Comparison

The maximum ICLR drawdown since its inception was -76.87%, smaller than the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for ICLR and CI.


Loading charts...

Drawdown Indicators


ICLRCIDifference

Max Drawdown

Largest peak-to-trough decline

-76.87%

-84.34%

+7.47%

Max Drawdown (1Y)

Largest decline over 1 year

-60.54%

-26.54%

-34.00%

Max Drawdown (3Y)

Largest decline over 3 years

-76.87%

-32.10%

-44.77%

Max Drawdown (5Y)

Largest decline over 5 years

-76.87%

-32.10%

-44.77%

Max Drawdown (10Y)

Largest decline over 10 years

-76.87%

-42.47%

-34.40%

Current Drawdown

Current decline from peak

-56.83%

-18.21%

-38.62%

Average Drawdown

Average peak-to-trough decline

-23.51%

-18.82%

-4.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.00%

14.51%

+12.49%

Volatility

ICLR vs. CI - Volatility Comparison

ICON Public Limited Company (ICLR) has a higher volatility of 18.56% compared to Cigna Corporation (CI) at 9.35%. This indicates that ICLR's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ICLRCIDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.56%

9.35%

+9.21%

Volatility (6M)

Calculated over the trailing 6-month period

66.63%

18.86%

+47.77%

Volatility (1Y)

Calculated over the trailing 1-year period

69.88%

33.18%

+36.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.08%

28.43%

+16.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.82%

30.75%

+7.07%

Dividends

ICLR vs. CI - Dividend Comparison

ICLR has not paid dividends to shareholders, while CI's dividend yield for the trailing twelve months is around 2.12%.


PositionTTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
2.12%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
ICLR
ICON Public Limited Company
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ICLR vs. CI - Financials Comparison

This section allows you to compare key financial metrics between ICON Public Limited Company and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
2.19B
68.49B
(ICLR) Total Revenue
(CI) Total Revenue
Values in USD except per share items

ICLR vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between ICON Public Limited Company and Cigna Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%20222023202420252026
27.4%
0
Portfolio components
ICLR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ICON Public Limited Company reported a gross profit of 599.39M and revenue of 2.19B. Therefore, the gross margin over that period was 27.4%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a gross profit of 0.00 and revenue of 68.49B. Therefore, the gross margin over that period was 0.0%.

ICLR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ICON Public Limited Company reported an operating income of 324.79M and revenue of 2.19B, resulting in an operating margin of 14.8%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported an operating income of 2.36B and revenue of 68.49B, resulting in an operating margin of 3.4%.

ICLR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ICON Public Limited Company reported a net income of -110.14M and revenue of 2.19B, resulting in a net margin of -5.0%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a net income of 1.65B and revenue of 68.49B, resulting in a net margin of 2.4%.


Frequently Asked Questions


ICLR and CI have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ICLR has higher volatility (18.56%) compared to CI (9.35%). In terms of maximum drawdown, ICLR dropped -76.87% vs CI's -84.34%.

ICLR currently has the higher Sharpe Ratio (0.16 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ICLR and CI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer